{"id":"https://openalex.org/W2398889174","doi":null,"title":"Phase I study of combination therapy with S-1 and weekly docetaxel for advanced gastric cancer.","display_name":"Phase I study of combination therapy with S-1 and weekly docetaxel for advanced gastric cancer.","publication_year":2007,"publication_date":"2007-07-01","ids":{"openalex":"https://openalex.org/W2398889174","mag":"2398889174","pmid":"https://pubmed.ncbi.nlm.nih.gov/17695429"},"language":"en","primary_location":{"id":"pmid:17695429","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17695429","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Clinical Trial, Phase I"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065856332","display_name":"Tomohiro Ozaki","orcid":"https://orcid.org/0000-0002-8178-4171","observed_orcids":["https://orcid.org/0000-0002-8178-4171"]},"institutions":[{"id":"https://openalex.org/I916559398","display_name":"Kindai University","ror":"https://ror.org/05kt9ap64","country_code":"JP","type":"education","lineage":["https://openalex.org/I916559398"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomohiro Ozaki","raw_affiliation_strings":["Department of Medical Oncology, Kinki University School of Medicine, Nara Hospital, Otoda, Ikoma, Nara, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Kinki University School of Medicine, Nara Hospital, Otoda, Ikoma, Nara, Japan","institution_ids":["https://openalex.org/I916559398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069272944","display_name":"Kenji Tamura","orcid":"https://orcid.org/0000-0002-3514-9927","observed_orcids":["https://orcid.org/0000-0002-3514-9927"]},"institutions":[{"id":"https://openalex.org/I916559398","display_name":"Kindai University","ror":"https://ror.org/05kt9ap64","country_code":"JP","type":"education","lineage":["https://openalex.org/I916559398"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kenji Tamura","raw_affiliation_strings":["Kindai University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kindai University","institution_ids":["https://openalex.org/I916559398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058524907","display_name":"Taroh Satoh","orcid":"https://orcid.org/0000-0002-4615-2638","observed_orcids":["https://orcid.org/0000-0002-4615-2638"]},"institutions":[{"id":"https://openalex.org/I916559398","display_name":"Kindai University","ror":"https://ror.org/05kt9ap64","country_code":"JP","type":"education","lineage":["https://openalex.org/I916559398"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Taroh Satoh","raw_affiliation_strings":["Kindai university"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kindai university","institution_ids":["https://openalex.org/I916559398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063817865","display_name":"Takayasu Kurata","orcid":"https://orcid.org/0000-0003-4123-3567","observed_orcids":["https://orcid.org/0000-0003-4123-3567"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takayasu Kurata","raw_affiliation_strings":["Osaka Medical College"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Osaka Medical College","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046628885","display_name":"Toshio Shimizu","orcid":"https://orcid.org/0000-0001-6632-0638","observed_orcids":["https://orcid.org/0000-0001-6632-0638"]},"institutions":[{"id":"https://openalex.org/I916559398","display_name":"Kindai University","ror":"https://ror.org/05kt9ap64","country_code":"JP","type":"education","lineage":["https://openalex.org/I916559398"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshio Shimizu","raw_affiliation_strings":["Kindai university"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kindai university","institution_ids":["https://openalex.org/I916559398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101955394","display_name":"Masaki Miyazaki","orcid":"https://orcid.org/0000-0001-8759-0645","observed_orcids":["https://orcid.org/0000-0001-8759-0645"]},"institutions":[{"id":"https://openalex.org/I916559398","display_name":"Kindai University","ror":"https://ror.org/05kt9ap64","country_code":"JP","type":"education","lineage":["https://openalex.org/I916559398"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masaki Miyazaki","raw_affiliation_strings":["Kindai university"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kindai university","institution_ids":["https://openalex.org/I916559398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072724155","display_name":"Isamu Okamoto","orcid":"https://orcid.org/0000-0002-7587-6096","observed_orcids":["https://orcid.org/0000-0002-7587-6096"]},"institutions":[{"id":"https://openalex.org/I916559398","display_name":"Kindai University","ror":"https://ror.org/05kt9ap64","country_code":"JP","type":"education","lineage":["https://openalex.org/I916559398"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Isamu Okamoto","raw_affiliation_strings":["Kindai university"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kindai university","institution_ids":["https://openalex.org/I916559398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100648645","display_name":"Kazuhiko Nakagawa","orcid":"https://orcid.org/0000-0003-1284-9776","observed_orcids":["https://orcid.org/0000-0003-1284-9776"]},"institutions":[{"id":"https://openalex.org/I916559398","display_name":"Kindai University","ror":"https://ror.org/05kt9ap64","country_code":"JP","type":"education","lineage":["https://openalex.org/I916559398"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuhiko Nakagawa","raw_affiliation_strings":["Kindai university"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kindai university","institution_ids":["https://openalex.org/I916559398"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108393803","display_name":"Masahiro Fukuoka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I916559398","display_name":"Kindai University","ror":"https://ror.org/05kt9ap64","country_code":"JP","type":"education","lineage":["https://openalex.org/I916559398"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masahiro Fukuoka","raw_affiliation_strings":["Kindai university"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kindai university","institution_ids":["https://openalex.org/I916559398"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1775,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.57636113,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":"4C","first_page":"2657","last_page":"65"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-gastric-cancer","display_name":"advanced gastric cancer","score":0.8479999899864197},{"id":"https://openalex.org/keywords/s-1","display_name":"S-1","score":0.9179999828338623},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9210000038146973},{"id":"https://openalex.org/keywords/weekly-docetaxel","display_name":"weekly docetaxel","score":0.8659999966621399},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.9559999704360962},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9300000071525574},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9210000038146973},{"id":"https://openalex.org/keywords/recommended-dose","display_name":"recommended dose","score":0.7730000019073486},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8069999814033508},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7490000128746033},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.6809999942779541},{"id":"https://openalex.org/keywords/stomatitis","display_name":"stomatitis","score":0.871999979019165},{"id":"https://openalex.org/keywords/oral-fluoropyrimidine","display_name":"oral fluoropyrimidine","score":0.6800000071525574}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.954506516456604},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9074705243110657},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7717847228050232},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.6869070529937744},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5911870002746582},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5851967334747314},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5693602561950684},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5472001433372498},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.49575886130332947},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4687766134738922},{"id":"https://openalex.org/C2779051857","wikidata":"https://www.wikidata.org/wiki/Q911386","display_name":"Stomatitis","level":2,"score":0.45747140049934387},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.43141528964042664},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3808709681034088}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005641","descriptor_name":"Tegafur","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005641","descriptor_name":"Tegafur","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005641","descriptor_name":"Tegafur","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010094","descriptor_name":"Oxonic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010094","descriptor_name":"Oxonic Acid","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010094","descriptor_name":"Oxonic Acid","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:17695429","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17695429","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W1883602322","https://openalex.org/W1910458543","https://openalex.org/W1915817595","https://openalex.org/W1959506700","https://openalex.org/W1968785826","https://openalex.org/W1973175225","https://openalex.org/W1973464765","https://openalex.org/W1974449546","https://openalex.org/W1974734959","https://openalex.org/W1976651872","https://openalex.org/W1992103975","https://openalex.org/W1992408996","https://openalex.org/W1993389431","https://openalex.org/W2004703251","https://openalex.org/W2005627135","https://openalex.org/W2008575122","https://openalex.org/W2018619890","https://openalex.org/W2038563455","https://openalex.org/W2043478531","https://openalex.org/W2052127115","https://openalex.org/W2056634859","https://openalex.org/W2077902459","https://openalex.org/W2104264282","https://openalex.org/W2111513457","https://openalex.org/W2119923371","https://openalex.org/W2139248078","https://openalex.org/W2152256906","https://openalex.org/W2158387151","https://openalex.org/W2161990928","https://openalex.org/W2170346929","https://openalex.org/W2288788326","https://openalex.org/W2311750399","https://openalex.org/W2336779220","https://openalex.org/W2340603784","https://openalex.org/W2404450510","https://openalex.org/W2442230112"],"related_works":["https://openalex.org/W2182849032","https://openalex.org/W2030772374","https://openalex.org/W1989449128","https://openalex.org/W2158387151","https://openalex.org/W3011268875","https://openalex.org/W2119923371","https://openalex.org/W2076512855","https://openalex.org/W2037572126","https://openalex.org/W2596613541","https://openalex.org/W3144321472"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,126,144],"primary":[2],"objective":[3],"of":[4,26,29,34,56,88,166,174,187],"this":[5],"study":[6,81,128],"was":[7,60,66,82,152,156,161],"to":[8],"determine":[9],"the":[10,15,19,148],"maximum":[11],"tolerated":[12],"dose":[13,21,55],"(MTD),":[14],"toxicity":[16,95],"profile":[17],"and":[18,31,73,135,141,171,180,189,194],"recommended":[20],"(RD)":[22],"for":[23,62,168,203],"phase":[24],"II":[25],"a":[27],"combination":[28],"S-1":[30,59,167,188],"weekly":[32],"administration":[33],"docetaxel.":[35],"PATIENTS":[36],"AND":[37],"METHODS:":[38],"Patients":[39],"with":[40,100,118],"histologically":[41],"diagnosed":[42],"recurrent":[43],"or":[44,121],"unresectable":[45],"locally":[46],"advanced":[47,204],"gastric":[48,205],"cancer":[49],"were":[50,91,139,191],"enrolled.":[51,92],"A":[52,79,86],"fixed":[53],"oral":[54],"80":[57],"mg/m2":[58,165,173],"given":[61],"3":[63,98,116,169],"weeks.":[64,78],"Docetaxel":[65],"infused":[67],"intravenously":[68],"on":[69,176],"day":[70,177],"1,":[71,178],"8":[72,179],"15,":[74,181],"repeated":[75],"every":[76,182],"5":[77,183],"pharmacokinetic":[80,127],"also":[83],"performed.":[84],"RESULTS:":[85],"total":[87],"14":[89],"patients":[90,111],"One":[93],"dose-limiting":[94],"(DLT)":[96],"(grade":[97,115],"diarrhea":[99],"febrile":[101,119],"neutropenia)":[102],"occurred":[103,108],"at":[104,112,147],"level":[105,113,162],"2.":[106],"DLTs":[107],"in":[109],"3/5":[110],"3,":[114],"stomatitis,":[117],"neutropenia":[120],"continuous":[122],"grade":[123],"4":[124],"neutropenia).":[125],"suggested":[129],"no":[130],"drug":[131],"interactions.":[132],"Overall":[133,154],"response":[134,145],"disease":[136],"control":[137],"rates":[138],"20%":[140],"80%,":[142],"respectively.":[143,197],"rate":[146],"RD":[149,160],"(level":[150],"2)":[151],"50%.":[153],"survival":[155],"9.4":[157],"months.":[158],"CONCLUSION:":[159],"2":[163],"(80":[164],"weeks":[170],"20":[172],"docetaxel":[175,190],"weeks).":[184],"Dose":[185],"intensities":[186],"48":[192],"mg/m2/week":[193],"12":[195],"mg/m2/week,":[196],"This":[198],"regimen":[199],"showed":[200],"promising":[201],"activity":[202],"cancer.":[206]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}